These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 18546237

  • 1. Efficacy and safety of argatroban in patients with heparin induced thrombocytopenia undergoing endovascular intervention for peripheral arterial disease.
    Baron SJ, Yeh RW, Cruz-Gonzalez I, Healy JL, Pomerantsev E, Garasic J, Drachman D, Rosenfield K, Jang IK.
    Catheter Cardiovasc Interv; 2008 Jul 01; 72(1):116-20. PubMed ID: 18546237
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome.
    Cruz-Gonzalez I, Sanchez-Ledesma M, Baron SJ, Healy JL, Watanabe H, Osakabe M, Yeh RW, Jang IK.
    J Thromb Thrombolysis; 2008 Apr 01; 25(2):214-8. PubMed ID: 17632689
    [Abstract] [Full Text] [Related]

  • 3. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study.
    Boyce SW, Bandyk DF, Bartholomew JR, Frame JN, Rice L.
    Am J Ther; 2011 Jan 01; 18(1):14-22. PubMed ID: 21079512
    [Abstract] [Full Text] [Related]

  • 4. Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
    Levine RL, Hursting MJ, McCollum D.
    Chest; 2006 May 01; 129(5):1167-75. PubMed ID: 16685006
    [Abstract] [Full Text] [Related]

  • 5. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
    Reddy BV, Grossman EJ, Trevino SA, Hursting MJ, Murray PT.
    Ann Pharmacother; 2005 Oct 01; 39(10):1601-5. PubMed ID: 16131539
    [Abstract] [Full Text] [Related]

  • 6. Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients.
    Gray A, Wallis DE, Hursting MJ, Katz E, Lewis BE.
    Clin Appl Thromb Hemost; 2007 Oct 01; 13(4):353-61. PubMed ID: 17911186
    [Abstract] [Full Text] [Related]

  • 7. Argatroban: a review of its use in the management of heparin-induced thrombocytopenia.
    Dhillon S.
    Am J Cardiovasc Drugs; 2009 Oct 01; 9(4):261-82. PubMed ID: 19655821
    [Abstract] [Full Text] [Related]

  • 8. Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis.
    Frame JN, Rice L, Bartholomew JR, Whelton A.
    Clin Ther; 2010 Apr 01; 32(4):626-36. PubMed ID: 20435232
    [Abstract] [Full Text] [Related]

  • 9. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
    Lewis BE, Wallis DE, Leya F, Hursting MJ, Kelton JG, Argatroban-915 Investigators.
    Arch Intern Med; 2010 Apr 01; 163(15):1849-56. PubMed ID: 12912723
    [Abstract] [Full Text] [Related]

  • 10. Use of argatroban during percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.
    Matthai WH.
    Semin Thromb Hemost; 1999 Apr 01; 25 Suppl 1():57-60. PubMed ID: 10357153
    [Abstract] [Full Text] [Related]

  • 11. Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.
    Bartholomew JR, Pietrangeli CE, Hursting MJ.
    Drugs Aging; 2007 Apr 01; 24(6):489-99. PubMed ID: 17571914
    [Abstract] [Full Text] [Related]

  • 12. Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Lewis BE, Matthai WH, Cohen M, Moses JW, Hursting MJ, Leya F, ARG-216/310/311 Study Investigators.
    Catheter Cardiovasc Interv; 2002 Oct 01; 57(2):177-84. PubMed ID: 12357516
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
    Dang CH, Durkalski VL, Nappi JM.
    Pharmacotherapy; 2006 Apr 01; 26(4):461-8. PubMed ID: 16553503
    [Abstract] [Full Text] [Related]

  • 14. Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia.
    Kondo LM, Wittkowsky AK, Wiggins BS.
    Ann Pharmacother; 2001 Apr 01; 35(4):440-51. PubMed ID: 11302409
    [Abstract] [Full Text] [Related]

  • 15. Argatroban therapy in women with heparin-induced thrombocytopenia.
    Jang IK, Baron SJ, Hursting MJ, Anglade E.
    J Womens Health (Larchmt); 2007 Apr 01; 16(6):895-901. PubMed ID: 17678460
    [Abstract] [Full Text] [Related]

  • 16. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.
    Lewis BE, Wallis DE, Berkowitz SD, Matthai WH, Fareed J, Walenga JM, Bartholomew J, Sham R, Lerner RG, Zeigler ZR, Rustagi PK, Jang IK, Rifkin SD, Moran J, Hursting MJ, Kelton JG, ARG-911 Study Investigators.
    Circulation; 2001 Apr 10; 103(14):1838-43. PubMed ID: 11294800
    [Abstract] [Full Text] [Related]

  • 17. Effect of body mass index on Argatroban therapy during percutaneous coronary intervention.
    Hursting MJ, Jang IK.
    J Thromb Thrombolysis; 2008 Jun 10; 25(3):273-9. PubMed ID: 17530465
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of argatroban and bivalirudine in patients with suspected heparin-induced thrombocytopenia.
    Vo QA, Lin JK, Tong LM.
    Ann Pharmacother; 2015 Feb 10; 49(2):178-84. PubMed ID: 25515865
    [Abstract] [Full Text] [Related]

  • 20. Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia.
    Guzzi LM, McCollum DA, Hursting MJ.
    J Thromb Thrombolysis; 2006 Dec 10; 22(3):169-76. PubMed ID: 17103051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.